Specialty	Neurology
Clinical Interests	Multiple Sclerosis
	Neuroimmunology
	Neurology
Languages	English
Gender	Male
E-mail	fred.lublin@mssm.edu
Education and Training	MD, Jefferson Medical College
	Residency, Internal Medicine, Bronx Municipal Hospital Center
	Residency, Neurology, New York Hospital
Awards	2001 Attending of the Year Award Mount Sinai Medical Center Neurology Residents
	2000 - Present Chairman, Research Programs Advisory Committee National Multiple Sclerosis Society
	1999 Hope Award National Multiple Sclerosis Society, Delaware Valley Chapter
	1999 McEwan Visiting Professorship & Lecture in Neurology University of Toronto
	1996 Milestone Award National Multiple Sclerosis Society, Delaware Valley Chapter

Fred D. Lublin, MD is the Saunders Family Professor of Neurology and the Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai Medical Center. He is an internationally renowned authority on the clinical and scientific aspects of MS and one of the foremost experts in experimental therapies.

As a neuroimmunologist, Dr. Lublin has a special interest in immune functions and abnormalities affecting the nervous system.  He has been involved in both basic science and clinical research.  In 2005, Dr. Lublin received a $25-million grant from the National Institutes of Health (NIH) to conduct a nationwide multi-center study on the effectiveness of combining two disease-modifying drugs. This grant was renewed in 2008, bringing the total allocated by the NIH to $44-million, one of the largest grants ever given for MS research.  

Learn more about Dr. Lublin's work as Principal Investigator in the CombiRx clinical trial, as this study is known, in Inside Mount Sinai. He is also currently involved in several new clinical research protocols on promising agents for treating various aspects of MS.

Dr. Lublin was chairman of the National Multiple Sclerosis Society (USA) advisory committee on clinical trials of new MS drugs; and he is currently chair of the Clinical Advisory Committee of the New York City Chapter of the National MS Society.  Dr. Lublin and his colleagues at the National MS Society (USA) have redefined the clinical course definitions of MS.

Dr. Lublin has published numerous scientific articles and belongs to many professional societies and advisory boards.  Dr. Lublin has served as a consultant to the NIH, as well as to pharmaceutical and biotech companies in all phases of drug development, and in preparation for drug presentation to the FDA and its advisory panels.

Dr. Lublin received his medical degree at Jefferson Medical College, Philadelphia, PA.  He completed his internship in Internal Medicine at the Bronx Municipal Hospital, Albert Einstein Medical Center, and his residency at the New York Hospital, Cornell Medical Center.  

Education and Training	MD, Jefferson Medical College
	Residency, Internal Medicine, Bronx Municipal Hospital Center
	Residency, Neurology, New York Hospital
Board Certification	Neurology

Specialty	Neurology
Clinical Interests	Multiple Sclerosis
	Neuroimmunology
	Neurology
Languages	English
Board Certification	Neurology

Miller A, Bourdette D, Cohen JA, Coyle PK, Lublin F, Paty DW, Rice GP, Weinstock-Guttman B, editors. Multiple Sclerosis. New York, Continuum; 1999. pp1-196.

Croul S, Lublin F, Del Valle L, Oshinsky RJ, Giordano A, Khalili K, Ritchie CK. The Cellular Response of JC Virus T-Antigen-Induced Brain Tumor Implants to a Murine Intra-Ocular Model. J Neuroimmunol 2000; 106: 181-188.

Wolinsky JS, Narayana PA, Noseworthy JH, Lublin F, Whitaker JN, Linde A, Gjorstrup P, Sullivan HC. Linomide in relapsing and secondary progressive MS: part II: MRI results. MRI Analysis Center of the University of Texas-Houston, Health Science Center, and the North American Linomide Investigators. Neurology 2000 May; 54(9): 1734-1741.

Noseworthy JH, Wolinsky JS, Lublin F, Whitaker JN, Linde A, Gjorstrup P, Sullivan HC. Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results. North American Linomide Investigators. Neurology 2000 May; 54(9): 1726-1733.

Whitaker JN, Wolinsky JS, Narayana PA, Bartolucci AA, Noseworthy JH, Lublin F, Linde A, Gjorstrup P, Sullivan HC, North American Linomide Investigators . Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis. Arch Neurol 2001 Jan; 58(1): 49-54.

Kalman B, Lublin F. Spectrum and classification of inflammatory demyelinating diseases of the central nervous system. Current Neurology and Neuroscience Reports, Demyelinating Disorders section 2001; 1: 249-256.

McDonald WI, Compston DA S, Edan G, Goodkin D, Hartung HP, Lublin F, McFarland HF, Paty D, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker B, Wolinsky JS. Diagnostic Criteria for MS: Guidelines from the International Panel on the Diagnosis of MS. Ann Neurol 2001; 50: 121-127.

Lublin F, Reingold SC. Placebo-controlled clinical trials in multiple sclerosis: ethical considerations. National Multiple Sclerosis Society (USA) Task Force on Placebo-Controlled Clinical Trials in MS. Ann Neurol 2001; 49: 677-681.

Mohamed FB, Vinitski S, Gonzalez CF, Faro SH, Lublin F, Knobler R, Gutierrez JE. Increased differentiation of intracranial white matter lesions by multispectral 3D-tissue segmentation: preliminary results. Magn Reson Imaging 2001; 19: 207-18.